How Biotech Cos. Can Utilize Synthetic Royalty Financing
Article | February 1, 2024
Law360
San Francisco partners Ryan Murr and Karen Spindler are the authors of “How Biotech Cos. Can Utilize Synthetic Royalty Financing” [PDF] published by Law360 on February 1, 2024.